Duration of Remission During Maintenance Cyclosporine Therapy for Psoriasis: Relationship to Maintenance Dose and Degree of Improvement During Initial Therapy

Archives of Dermatology

Volumn 131, Issue 7, 1995, Pages 791-795

  Ellis, Charles N ^a,b   Fradin, Mark S ^a,b   Hamilton, Ted A ^a,b   Voorhees, John J ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Affairs Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; NEPHROTOXICITY; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; CYCLOSPORINE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PSORIASIS; REMISSION INDUCTION; TIME FACTORS;

EID: 0029044672     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1995.01690190043008     Document Type: Article

References (35)

1. Ellis CN, Fradin MS, Messana JM, et al. Cyclosporine for plaque-type psoriasis: results of a multidose, double-blind trial. N Engl J Med. 1991; 324: 277-284.
2. Mueller W, Herrmann B. Cyclosporin A for psoriasis. N Engl J Med. 1979; 301: 555.
3. Harper JI, Keat ASC, Staughton RCD. Cyclosporine for psoriasis. Lancet. 1984; 2: 981-982.
4. Van Hooff JP, Leunissen KML, Staak WVD. Cyclosporin and psoriasis. Lancet. 1985; 1: 335.
5. Ellis CN, Gorsulowsky DC, Hamilton TA, et al. Cyclosporine improves psoriasis in a double-blind study. JAMA. 1986; 256: 3110-3116.
6. Marks J. Psoriasis. BMJ. 1986: 293:509.
7. Griffiths CEM, Powles AV. Leonard JN, et al. Clearance of psoriasis with low dose cyclosporin. BMJ. 1986; 293: 731-732.
8. Brookes DB. Clearance of psoriasis with low dose cyclosporin. BMJ. 1986; 293: 1098-1099.
9. van Joost T, Heule F, Stolz E, Beukers R. Short-term use of cyclosporin A in severe psoriasis. Br J Dermatol. 1986; 114: 615-620.
10. Wentzell JM, Baughman RD, O'Connor GT, Bernier GM Jr. Cyclosporine in the treatment of psoriasis. Arch Dermatol. 1987; 123: 163-165.
11. Picascia DD, Garden JM, Freinkel RK, Roenigk HH Jr. Treatment of resistant severe psoriasis with systemic cyclosporine. J Am Acad Dermatol. 1987; 17: 408-414.
12. Griffiths CEM, Powles AV, Baker BS., Fry L, Validimarsson H. Combination of cyclosporine A and topical corticosteroid in the treatment of psoriasis. Transplant Proc. 1988; 20(suppl 4): 50-52.
13. van Joost T, Bos JD, Heule F, Meinardi MMHM. Low-dose cyclosporin A in severe psoriasis: a double-blind study. Br J Dermatol. 1988; 118: 183-190.
14. Meinardi MMHM, Bos JD. Cyclosporine maintenance therapy in psoriasis. Transplant Proc. 1988; 20(suppl 4): 42-49.
15. Finzi AF, Mozzanica N, Cattaneo A, Chiappino G, Pigatto PD. Effectiveness of cyclosporine treatment in severe psoriasis: a clinical and immunologic study. J Am Acad Dermatol. 1989; 21: 91-97.
16. Heule F, Bousema MT, Laeijendecker R, van Joost T. Three long-term regimens with cyclosporin for psoriasis vulgaris. Acta Derm Venereol Suppl. 1989; 146: 171-175.
17. Meinardi MMHM, de Rie MA, Bos JD. Oral cyclosporin A in the treatment of psoriasis: an overview of studies performed in the Netherlands. Br J Dermatol. 1990; 122(suppl 36): 27-31.
18. Timonen P, Friend D, Abeywickrama K, Laburte C, von Graffenried B, Feutren G. Efficacy of low-dose cyclosporin A in psoriasis: results of dose-finding studies. Br J Dermatol. 1990; 122(suppl 36): 33-39.
19. Powles AV, Baker BS., Valdimarsson H, Hulme B, Fry L. Four years of experience with cyclosporin A for psoriasis. Br J Dermatol. 1990; 122(suppl 36): 13-19.
20. Tegelberg-Stassen MJAM, Lammers A, Van Floten WA, et al. Responsiveness of moderate psoriatic skin lesions to 1, 2, or 3 mg/kg/day ciclosporin A: a multicenter study. Eur J Dermatol. 1992; 2: 147-150.
21. Christophers E, Mrowietz U, Henneicke HH, Farber L, Welzel D. Cyclosporin A in psoriasis: interim results of a multicentre dose-finding study in severe chronic plaque-type psoriasis. In: Wolff K, ed. Cyclosporin A and the Skin. London, England: Royal Society of Medicine Services Ltd; 1992: 21-26. International Congress and Symposium Series No. 192.
22. Higgins E, Munro C, Marks J, Friedmann PS, Shuster S. Relapse rates in moderately severe chronic psoriasis treated with cyclosporin A. Br J Dermatol. 1989; 121: 71-74.
23. Studio Italiano Multicentrico nella Psoriasi (SIMPSO). Short- and long-term considerations concerning the management of plaque psoriasis with low-dose cyclosporin. Dermatology. 1993; 187(suppl 1): 19-29.
24. Laburte C, Grossman R, Abi-Rached J, Abeywickrama KH, Dubertret L. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis. Br J Dermatol. 1994; 130: 366-375.
25. Fradin MS, Ellis CN, Voorhees JJ. Management of patients and side effects during cyclosporine therapy for cutaneous disorders. J Am Acad Dermatol. 1990; 23: 1265-1275.
26. Powles AV, Carmichael D, Hulme B, et al. Renal function after long-term lowdose cyclosporin for psoriasis. Br J Dermatol. 1990; 122: 665-669.
27. Messana JM, Rocher LL, Ellis CN, et al. Effects of cyclosporine on renal function in psoriasis patients. J Am Acad Dermatol. 1990; 23: 1288-1293.
28. Feutren G, Abeywickrama K, Friend D, Von Graffenried B. Renal function and blood pressure in psoriatic patients treated with cyclosporin A. Br J Dermatol. 1990; 122(suppl 36): 57-69.
29. Zachariae H, Hansen HE, Kragballe K, Olsen S. Morphologic renal changes during cyclosporine treatment of psoriasis. J Am Acad Dermatol. 1992; 26: 415-419.
30. Brown AL, Wilkinson R, Thomas TH, et al. The effect of short-term low-dose cyclosporin on renal function and blood pressure in patients with psoriasis. Br J Dermatol. 1993; 128: 550-555.
31. Powles AV, Cook T, Hulme B, et al. Renal function and biopsy findings after 5 years' treatment with low-dose cyclosporin for psoriasis. Br J Dermatol. 1993; 128: 159-165.
32. Pei Y, Scholey JW, Katz A, Schachter R, Murphy GF, Cattran D. Chronic nephrotoxicity in psoriatic patients treated with low-dose cyclosporin. Am J Kidney Dis. 1994; 23: 528-536.
33. Young EW, Ellis CN, Messana JM, et al. A prospective study of renal stucture and function in psoriasis patients treated with cyclosporin. Kidney Int. 1994; 46: 1216-1222.
34. Mihatsch MJ, Wolff K. Consensus conference on cyclosporin A for psoriasis, February 1992. Br J Dermatol. 1992; 126: 621-623.
35. Fredriksson T, Pettersson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica. 1978; 157: 238-244.